Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.4B | 3.5B | 3.6B | 3.7B |
| Cost of revenue | 2.4B | 2.3B | 2.3B | 2.3B |
| Gross profit | 1.0B | 1.2B | 1.4B | 1.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 1.0B | 1.3B | 1.4B | 1.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 209M | 207M | 206M | 209M |
| Other income expense | 26M | -203M | 35M | 36M |
| Pretax income | 858M | 936M | 1.2B | 1.3B |
| Tax provision | 212M | 203M | 290M | 304M |
| Net income | 646M | 733M | 894M | 963M |
| Basic EPS | 0.3 | 0.4 | 0.5 | 0.5 |
| Diluted EPS | 0.3 | 0.4 | 0.5 | 0.5 |
| Basic average shares | 2.1B | 2.1B | 2.2B | 2.2B |
| Diluted average shares | 2.1B | 2.1B | 2.2B | 2.2B |
| EBITDA | 1.5B | 1.7B | 1.8B | 1.9B |
| Net income from continuing op. | 646M | 733M | 894M | 963M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |